Neuromuscular blockade in the intensive care unit. More than we bargained for

Am Rev Respir Dis. 1993 Jan;147(1):234-6. doi: 10.1164/ajrccm/147.1.234.

Authors

J Hansen-Flaschen¹, J Cowen, E C Raps

Affiliation

¹ Pulmonary and Critical Care Division, University of Pennsylvania School of Medicine, Philadelphia 19104-4283.

PMID: 8420423
DOI: 10.1164/ajrccm/147.1.234

No abstract available

MeSH terms

Humans
Intensive Care Units*
Muscular Diseases / chemically induced
Neuromuscular Blocking Agents / administration & dosage
Neuromuscular Blocking Agents / adverse effects*
Respiration, Artificial*
Risk Factors

Substances

Neuromuscular Blocking Agents